Cargando…
Pharmacokinetic Characterization and Tissue Distribution of Fusion Protein Therapeutics by Orthogonal Bioanalytical Assays and Minimal PBPK Modeling
Characterization of pharmacokinetic (PK) properties and target tissue distribution of therapeutic fusion proteins (TFPs) are critical in supporting in vivo efficacy. We evaluated the pharmacokinetic profile of an investigational TFP consisting of human immunoglobulin G4 fused to the modified interfe...
Autores principales: | Sugimoto, Hiroshi, Chen, Susan, Qian, Mark G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037219/ https://www.ncbi.nlm.nih.gov/pubmed/31991858 http://dx.doi.org/10.3390/molecules25030535 |
Ejemplares similares
-
Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK
por: Wagner, C, et al.
Publicado: (2015) -
ATLAS mPBPK: A MATLAB‐Based Tool for Modeling and Simulation of Minimal Physiologically‐Based Pharmacokinetic Models
por: Mavroudis, Panteleimon D., et al.
Publicado: (2019) -
Bioanalytical Assay Strategies and Considerations for Measuring Cellular Kinetics
por: Hays, Amanda, et al.
Publicado: (2022) -
A high-throughput bioanalytical assay to support pharmacokinetic interaction study of oxycodone and diazepam in Sprague Dawley rats
por: Pilli, Nageswara R., et al.
Publicado: (2020) -
Bioanalytical strategy used in development of pharmacokinetic (PK) methods that support biosimilar programs
por: Colbert, Alex, et al.
Publicado: (2014)